Phil Wilson
Plus aucun poste en cours
Profil
Phil Wilson formerly worked at Catalent Pharma Solutions, Inc., as Director-Global Operational Programs, Catalent Pharma Solutions, Inc., as Director-Global Operational Programs from 2007 to 2017, CryoPort, Inc., as SVP-Global Operations & Supply Chain, and Ancillare LP, as Vice President-Supply Chain.
Mr. Wilson received his graduate degree from The Pennsylvania State University.
Anciens postes connus de Phil Wilson
| Sociétés | Poste | Fin |
|---|---|---|
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01/06/2017 |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
Ancillare LP
 Ancillare LP Air Freight/CouriersTransportation Part of JSGP LLC, Ancillare LP is an American company that has been creating and innovating the Clinical Trial Ancillary Supply Chain (CTASC™) since 2006. The private company's focus is on proving that well-planned clinical supply chains can help accelerate approvals of life-saving therapies for patients. | Corporate Officer/Principal | - |
| CRYOPORT, INC. | Chief Operating Officer | - |
Formation de Phil Wilson
| The Pennsylvania State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRYOPORT, INC. | Transportation |
| Entreprise privées | 2 |
|---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Ancillare LP
Ancillare LP Air Freight/CouriersTransportation Part of JSGP LLC, Ancillare LP is an American company that has been creating and innovating the Clinical Trial Ancillary Supply Chain (CTASC™) since 2006. The private company's focus is on proving that well-planned clinical supply chains can help accelerate approvals of life-saving therapies for patients. | Transportation |
